Skip to content

Multiple Sclerosis Health Center

News and Features Related to Multiple Sclerosis

  1. Gilenya, First Oral MS Drug, Gets FDA Nod

    Sept. 22, 2010 -- The FDA today approved Novartis' Gilenya, the first oral drug for multiple sclerosis (MS). Gilenya (formerly spelled Gilenia, generic name fingolimod) last June received the overwhelming approval of an FDA expert advisory panel. Gilenya treats the relapsing form of MS. The drug sig

    Read Full Article
  2. Asthma Drug Albuterol May Help Treat MS

    Sept. 13, 2010 -- Adding the asthma drug albuterol to a treatment for multiple sclerosis (MS) improved walking ability and delayed the time to first relapse among patients in a newly published study. Patients starting daily injections of the MS drug glatiramer acetate -- known by the brand name Copa

    Read Full Article
  3. Seasonal Pattern Is Seen in MS Patients

    Aug. 31, 2010 -- Brain lesions associated with increased multiple sclerosis activity appear in patients more often between the months of March and August, a new study shows. Researchers also say warmer temperatures and solar radiation also seem to be linked to increased activity in MS patients. Scie

    Read Full Article
  4. Vitamin D Deficiency Linked to Autoimmune Diseases

    Aug. 23, 2010 -- There is now biologic evidence to back up the belief that vitamin D may protect against autoimmune diseases and certain cancers. A new genetic analysis lends support to the idea that the vitamin interacts with genes specific for colorectal cancer, multiple sclerosis, type 1 diabetes

    Read Full Article
  5. Active Mind May Protect MS Patients

    June 14, 2010 -- A small study of multiple sclerosis (MS) patients shows that maintaining an intellectually active lifestyle can help preserve learning and memory, even among patients with a high degree of brain damage. Although there’s no indication that being mentally engaged protects against brai

    Read Full Article
  6. FDA Panel Votes to Approve Gilenya, First Oral MS Drug

    June 10, 2010 - An FDA expert advisory panel today overwhelmingly recommended approval of Novartis's Gilenya, the first oral drug for multiple sclerosis (MS). Gilenya (generic name, fingolimod) would be used for the relapsing form of MS. The drug significantly reduces MS attacks. However, it has ser

    Read Full Article
  7. Survey Reveals Economic Toll of MS

    May 25, 2010 -- All over the world, of the people who quit working due to multiple sclerosis (MS), almost half did so within three years of being diagnosed with the debilitating disease, a new survey shows. The Multiple Sclerosis International Federation surveyed people with MS in 125 countries. The

    Read Full Article
  8. Multiple Sclerosis: Advances in Research and Treatment

    While the cause of multiple sclerosis (MS) is still not known, advances in treatment options and new understanding about the disease have been especially brisk in the past few years, researchers say. As a result, the future for the 400,000 Americans with the chronic, sometimes disabling disease may

    Read Full Article
  9. Caution Urged for Experimental MS Treatment

    April 19, 2010 (Toronto) -- People with multiple sclerosis (MS) should not undergo a controversial new treatment that's based on the theory that blocked neck veins can trigger MS, experts say. Neither the theory nor the treatment -- using angioplasty to open up the narrowed veins -- has been proved

    Read Full Article
  10. Experimental MS Drug Outperforms Standard Treatment

    April 15, 2010 (Toronto) -- Nearly 71% of people with early relapsing-remitting multiple sclerosis (MS) treated with the experimental MS drug alemtuzumab showed no evidence of disease activity four years into a study, researchers report. That's twice the percentage of patients treated with the appro

    Read Full Article
Displaying 91 - 100 of 256 Articles << Prev Page 6 7 8 9 10 11 12 13 14 15 Next >>

Today on WebMD

nerve damage
Learn how this disease affects the nervous system.
woman applying lotion
Ideas on how to boost your mood and self-esteem.
 
woman pondering
Get personalized treatment options.
man with hand over eye
Be on the lookout for these symptoms.
 
brain scan
ARTICLE
worried woman
ARTICLE
 
neural fiber
ARTICLE
white blood cells
VIDEO
 
sunlight in hands
ARTICLE
marijuana plant
ARTICLE
 
muscle spasm
ARTICLE
Neuron
ARTICLE